Original Research Paper
Hiv Life Cycle And Antiretroviral Treatment Drugs
Viruses are thought-out as intracellular parasites that are authentically dependent on living host cells for duplication. The foremost targets of human immune virus are class of differentiation 4+ helper T cells, that are coordinating with regulators of the humoral and cellular immune responses. Retroviruses are a family of viruses that give within its envelope a single-strand of ribonucleic acid, not a double strand of deoxyribonucleic acid. Antiretroviral medicines can decrease the capability of virus from duplication, and they also decrease the injury caused by virus over time to the persons immune system and other essential organs. Recently the recommendation for human immune virus/ acquired immune deficiency syndrome patient is dual nucleoside reverse transcriptase inhibitors + lone protease inhibitors (zidovudine + lamivudine + lopinavir/ritonavir) or dual nucleoside reverse transcriptase inhibitors + non-nucleoside reverse transcriptase inhibitors (zidovudine + lamivudine + nevirapine).
Keywords :Antiretroviral Treatment Apothegmatic Human Immune Virus Life Cycle Drugs
Cite This Article:
HIV LIFE CYCLE AND ANTIRETROVIRAL TREATMENT DRUGS, Gudisa Bereda, INTERNATIONAL JOURNAL OF ADVANCED MEDICINE : Volume-7 | Issue-6 | November-2023
[ Download PDF] [ Number of Downloads : 33 ]